Pao-Hsien Chu
Pao-Hsien Chu is an expert in Cardiology at Chang Gung Memorial Hospital (Taiwan). As of October 2026, ScienceLeadR ranks Pao-Hsien Chu in the top 1% of experts in Taiwan for Heart Failure and Myocardial Ischemia, and in the top 1% of experts worldwide for Epidemiologic Studies. Pao-Hsien Chu has authored 456 publications, the most recent in 2026, and is an investigator in 5 clinical trials. SLR score: 1,593 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Biochemistry - Public Health - Nephrology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Short Biography
Professor Pao-Hsien Chu, FCCP, FACC, FESC, FAPSC, formerly served as Chief of Cardiology and Director of the Heart Failure Center at CGMH. He previously led the Health Care Center and Department of Cardiology, since August 2025, serves as Director of the Institute of Stem Cell and Translational Cancer Research. He is Editor of Biomedical Journal and former Editor-in-Chief of Acta Cardiologica Sinica, with over 400 publications in cardiovascular medicine.
Organizations
Career arc: 1991 - 2026
Number : 456
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Lumikine Attenuates Ventilation-Induced Lung Injury in Mice with Lipopolysaccharide-Induced Lung Fibrosis. PMID 42883762 — lumican, activin receptors, lung, growth, transforming growth factors, acute lung injury, fibrosis, stress, physiological, lung injury, oxidative stress, pulmonary fibrosis, ventilation, lipopolysaccharides, extracellular matrix | Int J Mol Sci | 2026 | 0 |
| Clinical outcomes of sacubitril/valsartan in patients with mildly reduced or preserved ejection fraction and acute heart failure: a multi-institutional study. PMID 42860551 — kidney diseases, valsartan, receptors, angiotensin, heart failure, heart, multiple chronic conditions, heart failure, diastolic, kidney, angiotensins, therapeutics | Ann Med | 2026 | 0 |
| Comparing the Prognostic Performance Using Various Diagnostic Scoring Systems in Heart Failure With Preserved Ejection Fraction: Insights From the Nationwide Prospective Registry. PMID 42714432 — registries, mortality, heart diseases, heart failure, heart, heart failure, diastolic, natriuretic peptides | J Am Heart Assoc | 2026 | 0 |
| Human iPSC-EV-loaded nanofiber stent coatings accelerate vascular repair by enhancing EGFR/HIF-1α signaling and suppressing ROCK1-mediated remodeling. PMID 42699659 — cells, becaplermin, stents, muscle cells, growth, muscles, serum, muscle, smooth, micrornas, polylactic acid-polyglycolic acid copolymer, myocytes, smooth muscle, nanofibers | Mater Today Bio | 2026 | 0 |
| The benefit of LDL-C levels below 55 mg/dL in ESKD patients under statin treatment: A target trial emulation study. PMID 42685616 — mortality, cholesterol, ldl, arteriosclerosis, therapeutics, hydroxymethylglutaryl-coa reductase inhibitors | Atherosclerosis | 2026 | 0 |
Clinical Studies 5
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
LeadR Networks
Main global connection map